Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Peritoneal Effusion”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Testing effectiveness (Phase 2)WithdrawnNCT00908219
What this trial is testing

Bevacizumab to Prevent Malignant Ascites

Who this might be right for
Malignant Ascites
Baylor College of Medicine
Not applicableUnknownNCT03210298
What this trial is testing

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Who this might be right for
Peritoneum CancerPeritoneum NeoplasmPleural Cancer+12 more
Sabine Rhode 1,000
Early research (Phase 1)UnknownNCT06200376
What this trial is testing

A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer

Who this might be right for
Malignant Ascites
West China Hospital 10
Testing effectiveness (Phase 2)Study completedNCT01065246
What this trial is testing

Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant Ascites

Who this might be right for
Malignant Ascites Due to Epithelial Carcinoma
Neovii Biotech 8
Testing effectiveness (Phase 2)Looking for participantsNCT06433869
What this trial is testing

The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites

Who this might be right for
Malignant Ascites
Sun Yat-sen University 60
Early research (Phase 1)WithdrawnNCT03682744
What this trial is testing

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+4 more
Sorrento Therapeutics, Inc.
Not applicableUnknownNCT03550560
What this trial is testing

EUS-Guided Drainage of Refractory Malignant Ascites

Who this might be right for
Malignant Ascites
Hospital Universitario Virgen Macarena 100
Testing effectiveness (Phase 2)Study completedNCT00993655
What this trial is testing

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Canadian Cancer Trials Group 275
Not applicableStudy completedNCT02891369
What this trial is testing

Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Fondation Hôpital Saint-Joseph 30
Not applicableNot Yet RecruitingNCT06496919
What this trial is testing

A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant Tumors

Who this might be right for
Gastric Cancer
Wuhan University 300
Large-scale testing (Phase 3)Study completedNCT00836654
What this trial is testing

Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group

Who this might be right for
EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)Malignant Ascites
Neovii Biotech 258
Testing effectiveness (Phase 2)UnknownNCT03230708
What this trial is testing

Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites

Who this might be right for
Malignant Ascites
Hui ting Xu,MD 18
Not applicableEnded earlyNCT00028782
What this trial is testing

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Who this might be right for
Advanced Malignant MesotheliomaLocalized Malignant MesotheliomaMalignant Ascites+2 more
National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT04771676
What this trial is testing

Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Fudan University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196540
What this trial is testing

IP rmhTNF-NC + Tislelizumab + Palliat RT for GIT Tumor Malignant Ascites After Failed Std Tx

Who this might be right for
Digestive System Neoplasms
Sun Yat-sen University 78
Large-scale testing (Phase 3)UnknownNCT03475615
What this trial is testing

Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

Who this might be right for
Gastric CancerStomach Neoplasms
Fudan University 215
Not applicableEnrolling By InvitationNCT05745233
What this trial is testing

Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites

Who this might be right for
Malignant Ascites
China Medical University Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07397819
What this trial is testing

Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy

Who this might be right for
Malignant Ascites
Dong sheng Zhang 48
Early research (Phase 1)UnknownNCT05477927
What this trial is testing

Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases

Who this might be right for
Malignant Peritoneal EffusionMalignant AscitesSerous Cavity Metastatises
Sichuan University 58
Load More Results